Year archive

Vaxcell-Bio Therapeutics — 2021 filings

All 19 regulatory filings released by Vaxcell-Bio Therapeutics (323990) in 2021, sourced directly from the official regulator.

19 Filings

2021 Period

2021 filings (19)

Filing	Released	Lang
투자판단관련주요경영사항(동물용의약품 제조품목(박스루킨-15주)허가 신청 철회) Regulatory Filings	2021-12-15	Korean
주주명부폐쇄기간또는기준일설정 Regulatory Filings	2021-12-15	Korean
분기보고서 (2021.09) Interim / Quarterly Report 9M 2021	2021-11-15	Korean
반기보고서 (2021.06) Interim / Quarterly Report H1 2021	2021-08-13	Korean
[기재정정]사업보고서 (2020.12) Report Publication Announcement	2021-06-30	Korean
분기보고서 (2021.03) Interim / Quarterly Report Q1 2021	2021-05-17	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2021-04-15	Korean
주식등의대량보유상황보고서(일반) Major Shareholding Notification	2021-04-05	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2021-04-05	Korean
주식매수선택권행사 Share Issue/Capital Change	2021-03-29	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2021-03-25	Korean
주식매수선택권부여에관한신고 Share Issue/Capital Change	2021-03-25	Korean
감사보고서제출 Audit Report / Information FY 2020	2021-03-17	Korean
사업보고서 (2020.12) Annual Report FY 2020	2021-03-17	Korean
주주총회소집공고 AGM Information	2021-03-10	Korean
주주총회소집결의 AGM Information	2021-03-09	Korean
기타경영사항(특허권취득)(자율공시)(OX40L을 발현하는 배양보조세포 및 이를 이용한 자연살해세포 배양 방법) Regulatory Filings	2021-03-08	Korean
대표이사변경 Board/Management Information	2021-02-09	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2020	2021-02-09	Korean